EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Efficacy and Safety of CyberKnife-Based SBRT and Linear Accelerator-Based IMRT/VMAT for Thoracic Radiotherapy in Non-Small Cell Lung Cancer: A Propensity Score-Matched Real-World Analysis

Shuo Sun, Yi Duan, Guannan Yang, He Xiao, Xiuqiong Chen, Zhengbo Wang, Jungang Ma, Kunpu Su, Chuan Chen, Xueling Tong, Yanli Xiong, Xiao Yang und 1 weitere

Technology in Cancer Research & Treatment · 2026

DOI: 10.1177/15330338261494457 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Technology in Cancer Research & Treatment, 2026. Verfasst von Shuo Sun und 12 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Center, Daping Hospital & Army Medical Center of PLA, Army Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Radiosurgery, Lung Neoplasms, Radiotherapy, Intensity-Modulated. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The Clinical Innovation Cultivation Fund of Army Medical Center of PLA, Science-Health Joint Medical Scientific Research Project of Chongqing.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

CyberKnife-based stereotactic body radiotherapy (SBRT) has demonstrated favorable outcomes in multiple tumors. This study aimed to compare the efficacy and safety of CyberKnife-based SBRT versus linear accelerator (LINAC)-based IMRT/VMAT for thoracic radiotherapy in patients with non-small cell lung cancer (NSCLC) in a retrospective study.

Methods

In this retrospective cohort study, we retrospectively analyzed 461 NSCLC patients treated in our hospital. After propensity score matching (PSM), 138 patients (CyberKnife: 46; LINAC: 92) were matched. Median follow-up was 16.4 months (by reverse Kaplan-Meier method), and the short-term local control and early toxicity were compared.

Results

After PSM, baseline characteristics were well-balanced. No significant differences were observed in objective response rate ( P =0.838), disease control rate ( P =0.832), distribution of response categories ( P =0.972), or local progression-free survival (Log-Rank P =0.450). However, the CyberKnife group demonstrated superior safety. Symptomatic radiation pneumonitis (RP) (Grade≥2) was significantly lower (6.5% vs. 27.2%; OR=0.214, P =0.004). Notably, no Grade≥2 radiation esophagitis (RE) occurred in the CyberKnife group versus 18.5% with LINAC ( P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungRadiosurgeryLung NeoplasmsRadiotherapy, Intensity-ModulatedHumansFemalePropensity ScoreMaleAgedRetrospective StudiesParticle AcceleratorsTreatment OutcomeMiddle AgedAged, 80 and overRadiotherapy DosageNeoplasm Staging

Stichwörter der Autor:innen

CyberKnifeEfficacy and SafetyLinear accelerator (LINAC)Non-small cell lung cancerPropensity score matching

Autor:innen und Institutionen

  • Cancer Center, Daping Hospital & Army Medical Center of PLA, Army Medical University, Chongqing, China.
  • Department of Oncology, The 983rd Hospital of Joint Logistics Support Forces of the PLA, Tianjin, China.
  • Radiobiology of Cancer Key Laboratory of Chongqing Education Commission of China, Chongqing, China.

ORCID-Profile: Mengxia Li

Förderung

  • The Clinical Innovation Cultivation Fund of Army Medical Center of PLA
  • Science-Health Joint Medical Scientific Research Project of Chongqing

Zitieren

APA

Sun, S., Duan, Y., Yang, G., Xiao, H., Chen, X., Wang, Z., Ma, J., Su, K., Chen, C., Tong, X., Xiong, Y., Yang, X., & Li, M. (2026). Efficacy and Safety of CyberKnife-Based SBRT and Linear Accelerator-Based IMRT/VMAT for Thoracic Radiotherapy in Non-Small Cell Lung Cancer: A Propensity Score-Matched Real-World Analysis. Technology in Cancer Research & Treatment. https://doi.org/10.1177/15330338261494457

Vancouver

Sun S, Duan Y, Yang G, Xiao H, Chen X, Wang Z, et al. Efficacy and Safety of CyberKnife-Based SBRT and Linear Accelerator-Based IMRT/VMAT for Thoracic Radiotherapy in Non-Small Cell Lung Cancer: A Propensity Score-Matched Real-World Analysis. Technology in Cancer Research & Treatment. 2026. doi:10.1177/15330338261494457

BibTeX
@article{Sun2026,
  author = {Sun, Shuo and Duan, Yi and Yang, Guannan and Xiao, He and Chen, Xiuqiong and Wang, Zhengbo and Ma, Jungang and Su, Kunpu and Chen, Chuan and Tong, Xueling and Xiong, Yanli and Yang, Xiao and Li, Mengxia},
  title = {Efficacy and Safety of CyberKnife-Based SBRT and Linear Accelerator-Based IMRT/VMAT for Thoracic Radiotherapy in Non-Small Cell Lung Cancer: A Propensity Score-Matched Real-World Analysis},
  journal = {Technology in Cancer Research & Treatment},
  year = {2026},
  doi = {10.1177/15330338261494457}
}
Kostenlos starten →